<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578810/" ref="ordinalpos=897&amp;ncbi_uid=4649216&amp;link_uid=PMC3578810" image-link="/pmc/articles/PMC3578810/figure/pone-0057231-g005/" class="imagepopup">Figure 5. Injection of F13A suppresses the effects of apelin on glycogen synthesis and insulin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in TNF-α-treated mice..  From: Apelin Ameliorates TNF-?-Induced Reduction of Glycogen Synthesis in the Hepatocytes through G Protein-Coupled Receptor APJ. </a></div><br /><div class="p4l_captionBody">F13A (20 µg/mouse) or/and apelin 13 (20 nmol/kg) was injected in TNF-α-treated C57BL/6J mice. Injection of F13A suppressed the effects of apelin on glycogen synthesis (A) and insulin signaling pathway (B) in TNF-α-treated mice. Data represent the means ± S.E.M., n = 5 mice per group. * p&lt;0.05; ** p&lt;0.01 and *** p&lt;0.001 by ANOVA test.</div></div>